P2.90. A phase II trial of ZD 1839 (Gefitinib) for advanced cutaneous squamous cell carcinoma of head and neck

✍ Scribed by Weber, R.S.; Glisson, B.S.; Taylor, S.A.; Hanna, E.Y.; El-Naggar, A.K.; Chambers, M.S.

• Book ID: 119336902
• Publisher: Elsevier Science
• Year: 2009
• Weight: 38 KB
• Volume: 3
• Category: Article
• ISSN: 1744-7895
• DOI: 10.1016/j.oos.2009.06.493